Early Stage Oropharyngeal Carcinomas: Comparing Quality of Life for Different Treatment Modalities

Table 3

EORTC-QLQ-H&N35 scores for all three treatment groups.

Item	OP	OPRT	OPRCT
	Median (95%-confidence interval of mean)	Median (95%-confidence interval of mean)	Median (95%-confidence interval of mean)
HN pain	0 (3.37–13.97)	8.33 (8.37–24.39)	8.33 (12.40–24.76)
HN swallowing	0 (3.78–20.88)	25.00 (19.34–32.39)	20.83 (18.82–29.44)
HN senses	0 (2.72–15.94)	0 (8.15–29.78)	0 (11.69–27.20)
HN speech	0 (0.58–16.31)	11.11 (11.67–28.18)	0 (9.39–22.56)
HN social eating	0 (2.25–22.42)	25.00 (16.18–37.65)	20.833 (18.97–35.20)
HN social contact	0 (0.48–6.45)	0 (3.21–19.32)	0 (4.21–13.29)
HN sexuality	0 (8.08–31.92)	0 (12.14–39.58)	0 (17.08–37.78)
HN teeth	0 (6.54–36.13)	0 (16.11–48.25)	0 (17.59–40.74)
HN opening mouth	0 (5.68–34.32)	33.33 (22.67–50.89)	33.33 (25.58–46.64)
HN dry mouth	0 (14.30–44.36)	100 (66.78–89.54)	66.67 (49.93–72.29)
HN sticky saliva	0 (3.60–23.06)	66.67 (37.11–66.33)	66.67 (37.50–59.72)
HN coughed	0 (12.41–35.59)	33.33 (16.65–40.82)	33.33 (23.38–41.89)
HN felt ill	0 (3.03–15.64)	0 (1.71–23.58)	0 (8.20–25.14)
HN pain killers	0 (19.36–60.64)	0 (10.28–44.89)	0 (17.65–44.85)
HN nutritional supplements	0 (−4.26–12.26)	0 (7.57–40.70)	0 (5.73–27.60)
HN feeding tube	0 (−1.69–25.69)	0 (−2.91–16.71)	0 (0.22–16.44)
HN weight loss	0 (6.01–41.99)	0 (0.44–27.14)	0 (2.80–22.20)
HN weight gain	0 (9.08–46.92)	0 (0.44–27.14)	0 (−0.85–13.35)